Related Experiment Video

Updated: Aug 7, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Atherosclerosis and rheumatoid arthritis]

Tomasz Löwenhoff1, Piotr Głuszko

  • 1Zakład Reumatologii i Balneologii, Collegium Medicum, Uniwersytetu Jagiellońskiego, Kraków. zruj@mp.pl

Przeglad Lekarski
|June 22, 2006
PubMed

Insights

Patients with rheumatoid arthritis (RA) face increased cardiovascular disease (CVD) risk, primarily due to systemic inflammation driving atherosclerosis. RA-specific inflammatory factors, not just traditional risks, are key to this heightened cardiovascular risk.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Context:

  • Rheumatoid arthritis (RA) is linked to a higher incidence of cardiovascular diseases (CVD), including myocardial infarction and stroke.
  • CVD is the leading cause of mortality in RA patients.
  • Traditional CVD risk factors show inconsistent associations in RA patients.

Purpose:

  • To review the evidence linking RA-specific inflammatory factors to cardiovascular disease.
  • To discuss the role of systemic inflammation in endothelial dysfunction and atherosclerosis development in RA.
  • To highlight the interplay between inflammatory mediators and atherosclerosis pathogenesis.

Summary:

  • Systemic inflammation in RA, mediated by cytokines like TNF-alpha, IL-1, and IL-6, and C-reactive protein, is implicated in endothelial cell damage and accelerated atherosclerosis.
  • Atherosclerosis, a chronic inflammatory condition, can lead to acute cardiovascular events through plaque rupture and thrombosis.
  • The review focuses on the pathogenic mechanisms connecting RA and atherosclerosis, emphasizing inflammatory pathways.

Impact:

  • Provides a comprehensive overview of the inflammatory mechanisms underlying CVD in RA.
  • Highlights the critical role of RA-specific factors in cardiovascular risk assessment.
  • Informs clinical practice and future research directions for managing cardiovascular complications in RA.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...